Since drugs that possess anti-inflammatory effects, like dexamethasone and glycyrrhizin, act through these pathways to produce similar patterns of increased AQP5 expression, they could be anticipated to exert therapeutic effects by regulating the expression of AQPs in AR or CRS. This evidence concerns the gene AQP5 and congenital rubella syndrome.